Biotech Receives Device Approval in Five More Countries; Revenue Up 122% YOY

Source: Streetwise Reports   10/25/2017 Maxim Group reported on this firm’s Q3/17 earnings, as well as its progress in obtaining international regulatory clearances for its medical system. According to an Oct. 18 . . . → Read More: Biotech Receives Device Approval in Five More Countries; Revenue Up 122% YOY Similar Articles: Maxim Raises Target Price of Biotech Company Loan Provides Driver for Growth for Medical Device Firm Biotech with Alzheimer’s Focus Makes Progress on Several Fronts